Stockscreener 앱 받기
0.446
3.58%
0.0154
전일 마감가:
$0.4306
열려 있는:
$0.44
하루 거래량:
40,140
Relative Volume:
0.83
시가총액:
$4.78M
수익:
$105.10K
순이익/손실:
$-4.30M
주가수익비율:
-1.2083
EPS:
-0.3691
순현금흐름:
$-3.91M
1주 성능:
-14.43%
1개월 성능:
-23.13%
6개월 성능:
-36.29%
1년 성능:
-65.16%
1일 변동 폭
$0.431
$0.49
1주일 범위
$0.43
$0.5282
52주 변동 폭
$0.387
$2.01
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
0.446 | 4.78M | 105.10K | -4.30M | -3.91M | -0.3691 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Gelteq Ltd 주식(GELS)의 최신 뉴스
Gelteq Limited Ordinary Shares (NASDAQ: GELS) Share Price, GELS Stock News, GELS Share Price & Updates - kalkine.ca
Gelteq Limited Ordinary Shares (NASDAQ: GELS) Share Price, GELS Stock News, GELS Share Price & Updates - kalkine.com.au
GELS: Gelteq Ltd. Latest Stock Price, Analysis, News and Trading Ideas - stocktwits.com
Nasdaq Gains Over 200 Points; US Weekly Jobless Claims Edge Higher - benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Gelteq Ltd (GELS) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Gelteq Ltd (GELS) Earnings Date & Reports & Earnings News - TradingKey
Gelteq Ltd (GELS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Gelteq Ltd (GELS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GELS|Gelteq Ltd|Price:0.670|Chg%:-0.031 - TradingKey
Gelteq Ltd (GELS) Balance Sheet - TradingKey
Gelteq Ltd (GELS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Gelteq Ltd (GELS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Gelteq Ltd (GELS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Gelteq Ltd (GELS) Cash Flow - TradingKey
Gelteq Ltd (GELS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Gelteq Ltd (GELS) Institutional Confidence - TradingKey
Gelteq Ltd (GELS) Income Statement - TradingKey
GELS|Gelteq Ltd|Price:0.701|Chg%:-0.042 - TradingKey
Gelteq Limited (GELS) Surges 9.39%, Approaching Key Resistance at $0.78Value ETF - dars.gov.et
Gelteq | 3: Initial statement of beneficial ownership of securities- Givoni Nathan J - Moomoo
Gelteq | 3: Initial statement of beneficial ownership of securities- Karp Bradley Glenn - Moomoo
Gelteq (GELS) wins shareholder approval and closes $2.5M second tranche note - Stock Titan
GELSGelteq Ltd Short Interest - Finviz
GELSGelteq Ltd Latest SEC Filings - Finviz
Gelteq (GELS) faces $5.3M working capital deficit and rising debt - Stock Titan
Gelteq Company Profile & Introduction - Moomoo
Gelteq Ltd (GELS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Gelteq Ltd (GELS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Gelteq Ltd (GELS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Gelteq Ltd (GELS) Institutional Confidence - TradingKey
Gelteq Ltd (GELS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Gelteq Ltd (GELS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Gelteq advances clinical programs across pharmaceutical and veterinary applications By Investing.com - Investing.com India
Gelteq advances clinical programs across pharmaceutical and veterinary applications By Investing.com - Investing.com Australia
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs - The Manila Times
Gelteq lines up first human trial, vet study and $3.5M financing - Stock Titan
Gelteq Ltd (GELS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Gelteq advances clinical programs across pharmaceutical and veterinary applications - Investing.com
Gelteq Ltd (GELS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Gelteq Ltd (GELS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GELS Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
$Gelteq (GELS.US)$ thank you - Moomoo
GELSGelteq Ltd Earnings - Finviz
What's Going On With Gelteq Stock Friday?Gelteq (NASDAQ:GELS) - Benzinga
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - The Manila Times
Dogs accept gels that hide bitter medicine, Gelteq trials show - Stock Titan
Gelteq Ltd (GELS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.81%
자본화:
|
볼륨(24시간):